uniQure N.V. planned insider sales
In the last twelve months insiders at uniQure N.V. filed 34 Form 144 notices of planned sales, 639,911 shares worth $21.8 million at the time of filing, from 12 sellers. The latest, filed 2 July 2026: Kapusta Matthew C (officer, director, CEO AND managing director), 21,082 shares worth $951,932, planned for around 2 July 2026 through CITIGROUP GLOBAL MARKETS.
| Filed | Seller | Relationship | Shares | Value | Planned sale | Sold, per Form 4 | Broker | How acquired | Filing |
|---|---|---|---|---|---|---|---|---|---|
| 2 July 2026 | Kapusta Matthew C | Officer, Director, CEO AND MANAGING DIRECTOR | 21,082 | $951,932 | 2 July 2026 | 21,082 shares from 2 July 2026 | CITIGROUP GLOBAL MARKETS | Stock option exercise and sale | Form 144 |
| 30 June 2026 | Kaye Jack | Director | 21,167 | $983,033 | 30 June 2026 | 21,167 shares from 30 June 2026 | Citigroup Global Markets, Inc | Stock option exercise pursuant to 10b51 plan | Form 144 |
| 30 June 2026 | Abi-Saab Walid | Chief Medical Officer | 30,000 | $1.4 million | 30 June 2026 | 30,000 shares from 30 June 2026 | Citigroup Global Markets, Inc | Stock option exercise pursuant to 10b51 plan; Vested shares resulting from restricted Stock Vesting | Form 144 |
| 26 June 2026 | Abi-Saab Walid | Chief Medical Officer | 1,434 | $67,197 | 26 June 2026 | 1,434 shares from 26 June 2026 | Citigroup Global Markets, Inc | Restricted Stock Units Vesting | Form 144 |
| 25 June 2026 | Kapusta Matthew C | Officer, Director, CEO AND MANAGING DIRECTOR | 28,716 | $1.4 million | 25 June 2026 | 35,412 shares from 24 June 2026 | CITIGROUP GLOBAL MARKETS | Stock option exercise and sale | Form 144 |
| 24 June 2026 | Kapusta Matthew C | Officer, Director, CEO AND MANAGING DIRECTOR | 6,696 | $334,800 | 24 June 2026 | No matching Form 4 sale | CITIGROUP GLOBAL MARKETS | Stock option exercise and sale; Vested Stock from PSU and RSU | Form 144 |
| 18 June 2026 | Kapusta Matthew C | Officer, Director, CEO AND MANAGING DIRECTOR | 41,671 | $1.9 million | 18 June 2026 | 206,100 shares from 17 June 2026 | CITIGROUP GLOBAL MARKETS | Stock option exercise and sale; Vested Stock from PSU and RSU | Form 144 |
| 17 June 2026 | Kaye Jack | Director | 5,295 | $225,393 | 17 June 2026 | 5,295 shares from 17 June 2026 | Citigroup Global Markets, Inc | Stock option exercise pursuant to 10b51 plan | Form 144 |
| 17 June 2026 | Balachandran Madhavan | Director | 11,685 | $526,463 | 17 June 2026 | 11,685 shares from 17 June 2026 | Citigroup Global Markets, Inc | Stock option exercise and sale Pursuant to 10b5-1 plan | Form 144 |
| 17 June 2026 | Kapusta Matthew C | Officer, Director, CEO AND MANAGING DIRECTOR | 164,429 | $7.1 million | 17 June 2026 | No matching Form 4 sale | CITIGROUP GLOBAL MARKETS | Stock option exercise and sale pursuant to 10b51 plan; Vested Stock from PSU and RSU pursuant to 10b51 plan | Form 144 |
| 15 June 2026 | Potts Jeannette | Officer, CHIEF LEGAL OFFICER | 5,237 | $144,886 | 15 June 2026 | 5,237 shares from 15 June 2026 | CITIGROUP GLOBAL MARKETS | RESTRICTED STOCK UNITS VESTING | Form 144 |
| 11 June 2026 | Springhorn Jeremy P. | Director | 1,993 | $53,938 | 11 June 2026 | 1,993 shares from 11 June 2026 | Citigroup Global Markets, Inc | Restricted stock unit vesting | Form 144 |
| 11 June 2026 | Jacques Rachelle Suzanne | Director | 1,993 | $53,938 | 11 June 2026 | 1,993 shares from 11 June 2026 | Citigroup Global Markets, Inc | Restricted stock unit vesting | Form 144 |
| 11 June 2026 | Post Leonard E | Director | 1,993 | $53,938 | 11 June 2026 | 1,993 shares from 11 June 2026 | Citigroup Global Markets, Inc | Restricted stock unit vesting | Form 144 |
| 11 June 2026 | Meek David D. | Director | 1,993 | $53,938 | 11 June 2026 | 1,993 shares from 11 June 2026 | Citigroup Global Markets, Inc | Restricted stock unit vesting | Form 144 |
| 11 June 2026 | Kaye Jack | Director | 1,993 | $53,938 | 11 June 2026 | 1,993 shares from 11 June 2026 | Citigroup Global Markets, Inc | Restricted stock units vesting | Form 144 |
| 11 June 2026 | Gut Robert | Director | 2,726 | $73,776 | 11 June 2026 | 10,278 shares from 10 June 2026 | Citigroup Global Markets, Inc | Restricted stock unit vesting | Form 144 |
| 11 June 2026 | Balachandran Madhavan | Director | 11,993 | $324,578 | 11 June 2026 | 11,993 shares from 11 June 2026 | Citigroup Global Markets, Inc | Restricted stock unit vesting; Stock option exercise and sale Pursuant to 10b5-1 plan | Form 144 |
| 11 June 2026 | O'Keefe Kylie | Officer, Chief Customer and Strategy Officer | 15,936 | $431,290 | 11 June 2026 | 15,936 shares from 11 June 2026 | CITIGROUP GLOBAL MARKETS | Restricted Stock Units Vesting | Form 144 |
| 10 June 2026 | Gut Robert | Director | 7,552 | $196,725 | 10 June 2026 | No matching Form 4 sale | Citigroup Global Markets, Inc | Stock Options Exercise and Sale pursuant to 10B5-1 Plan; Vested Shares Pursuant to 10b5-1 plan | Form 144 |
| 3 June 2026 | Kaye Jack | Director | 2,645 | $79,384 | 3 June 2026 | 2,645 shares from 3 June 2026 | Citigroup Global Markets, Inc. | Stock Options Exercise and Sale Pursuant to 10B5-1 Plan | Form 144 |
| 8 May 2026 | Abi-Saab Walid | Chief Medical Officer | 45,000 | $1.1 million | 8 May 2026 | 45,000 shares from 8 May 2026 | Citigroup Global Markets, Inc | Stock options exercise; Vested Shares | Form 144 |
| 4 March 2026 | Potts Jeannette | Officer, CHIEF LEGAL AND COMPLIANCE OFFICER | 3,412 | $30,927 | 4 March 2026 | 3,412 shares from 4 March 2026 | CITIGROUP GLOBAL MARKETS | RESTRICTED STOCK UNITS VESTING | Form 144 |
| 4 March 2026 | Klemt Christian | Officer, CFO | 12,000 | $108,770 | 4 March 2026 | 12,000 shares from 4 March 2026 | CITIGROUP GLOBAL MARKETS | RESTRICTED STOCK UNITS VESTING | Form 144 |
| 4 March 2026 | Kapusta Matthew C | Director | 14,581 | $132,165 | 4 March 2026 | 14,581 shares from 4 March 2026 | CITIGROUP GLOBAL MARKETS | RESTRICTED STOCK UNITS VESTING | Form 144 |
| 2 March 2026 | Potts Jeannette | Officer, CHIEF LEGAL AND COMPLIANCE OFFICER | 8,578 | $85,336 | 2 March 2026 | 8,578 shares from 2 March 2026 | CITIGROUP GLOBAL MARKETS | RESTRICTED STOCK UNITS VESTING | Form 144 |
| 2 March 2026 | Klemt Christian | Officer, CFO | 12,832 | $127,655 | 2 March 2026 | 12,532 shares from 2 March 2026 | CITIGROUP GLOBAL MARKETS | RESTRICTED STOCK UNITS VESTING | Form 144 |
| 2 March 2026 | Kapusta Matthew C | Director | 34,437 | $342,586 | 2 March 2026 | 34,437 shares from 2 March 2026 | CITIGROUP GLOBAL MARKETS | RESTRICTED STOCK UNITS VESTING | Form 144 |
| 25 February 2026 | Klemt Christian | Officer, CFO | 6,217 | $148,321 | 25 February 2026 | 6,217 shares from 25 February 2026 | CITIGROUP GLOBAL MARKETS | RESTRICTED STOCK UNITS VESTING | Form 144 |
| 25 February 2026 | Kapusta Matthew C | Director | 12,378 | $295,307 | 25 February 2026 | 12,378 shares from 25 February 2026 | CITIGROUP GLOBAL MARKETS | RESTRICTED STOCK UNITS VESTING | Form 144 |
| 12 January 2026 | Gut Robert | Director | 25,613 | $676,695 | 12 January 2026 | 25,613 shares from 12 January 2026 | Citigroup Global Markets, Inc | Stock Options Exercise and Sale pursuant to 10B5-1 Plan; Vested shares; vested shares | Form 144 |
| 9 January 2026 | Kaye Jack | Director | 6,390 | $174,330 | 9 January 2026 | 6,390 shares from 9 January 2026 | Citigroup Global Markets, Inc | Stock Options Exercise and Sale pursuant to 10B5-1 Plan | Form 144 |
| 6 November 2025 | Gut Robert | Director | 31,434 | $819,170 | 6 November 2025 | 31,434 shares from 6 November 2025 | CITIGROUP GLOBAL MARKETS | STOCK OPTION EXERCISE AND SALE PURSUANT TO 10B51 PLAN; VESTED SHARES | Form 144 |
| 4 November 2025 | Kaye Jack | Director | 38,810 | $1.3 million | 4 November 2025 | 38,810 shares from 4 November 2025 | CITIGROUP GLOBAL MARKETS | STOCK OPTION EXERCISE AND SALE PURSUANT TO 10B51 PLAN | Form 144 |
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.